BioStock: “Mentice’s solutions will become even more crucial in the future”, says new CEO
Mentice has announced the appointment of Frans Venker as its new CEO, effective January 1, 2025. He brings over 25 years of industry experience, with a strong background in driving innovation and growth in medical imaging and therapy solutions.
Read the full article at biostock.se:
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se